The COMPLIANCE 360° trial: A randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease

Journal of Invasive Cardiology

Volumn 26, Issue 8, 2014, Pages 355-360

  Dattilo, Raymond ^a   Himmelstein, Stevan I ^b   Cuff, Robert F ^c  

^a St Francis Heart and Vascular Center Flint Hills Heart   (United States)

^b Memphis Heart Clinic   (United States)

^c SPECTRUM HEALTH   (United States)

Author keywords

orbital atherectomy; superficial femoral artery

Indexed keywords

AGED; ARTERIAL STENT; ARTICLE; ATHERECTOMY; CALCIFIED FEMOROPOPLITEAL DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EMERGENCY CARE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SUPERFICIAL FEMORAL ARTERY; ADVERSE DRUG REACTION; ADVERSE EFFECTS; CALCINOSIS; CLINICAL TRIAL; COMPLICATION; DEVICES; DUPLEX DOPPLER ULTRASONOGRAPHY; FEMORAL ARTERY; INTRAOPERATIVE COMPLICATIONS; LOWER LIMB; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROCEDURES; STENT; TREATMENT OUTCOME; VASCULARIZATION;

AGED; ANGIOPLASTY, BALLOON; ATHERECTOMY; CALCINOSIS; FEMALE; FEMORAL ARTERY; HUMANS; INTRAOPERATIVE COMPLICATIONS; LONG TERM ADVERSE EFFECTS; LOWER EXTREMITY; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PILOT PROJECTS; POPLITEAL ARTERY; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 84899867452     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Smouse HB, Nikanorov A, LaFlash D. Biomechanical forces in the femoropopliteal arterial segment. Endovascular Today. 2005;4:60-66.
2. Scheinert D, Scheinert S, Sax J et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45(2):312-315.
3. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Nagata S. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: Experience of 4 years. JACC Cardiovasc Interv. 2009;2(7):665-671.
4. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3(3):267-276.
5. Krankenberg H, Schluter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: The femoral artery stenting trial (FAST). Circulation. 2007;116(3):285-292.
6. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992;86(1):64-70.
7. Safian RD, Niazi K, Runyon JP, et al. Orbital atherectomy for infrapopliteal disease: Device concept and outcome data for the OASIS trial. Catheter Cardiovasc Interv. 2009;73(3):406-412.
8. Adams GL, Khanna PK, Staniloae CS, Abraham JP, Sparrow EM. Optimal techniques with the Diamondback 360° System achieve effective results for the treatment of peripheral arterial disease. J Cardiovasc Transl Res. 2011;4(2):220-229. Epub 2011 Feb 11.
9. Dake MD, Ansel GM, Jaff MR, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: Twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4(5):495-504. Epub 2011 Sep 27.
10. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115(21):2745-2749. Epub 2007 May 14.
11. Clark TW, Groffsky JL, Soulen MC. Predictors of long-term patency after femoropopliteal angioplasty: Results from the STAR registry. J Vasc Interv Radiol. 2001;12(8):923-933.
12. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Percutaneous superficial femoral artery interventions for claudication-does runoff matter? Ann Vasc Surg. 2008;22(6):790-798.